FDA Guidances Outline User Fee Collection Policy, Small Business Criteria
This article was originally published in The Gray Sheet
Executive Summary
Modular premarket applications will be exempt from device user fees if FDA received the initial module of the PMA prior to Oct. 1, 2002
You may also be interested in...
MDUFMA Guidance Clarifies Appropriate Bundling Use For Reprocessed SUDs
A Class II special surgical implant device used to implant a Class III device may be bundled in the same premarket approval application, according to an FDA bundling guidance
MDUFMA Guidance Clarifies Appropriate Bundling Use For Reprocessed SUDs
A Class II special surgical implant device used to implant a Class III device may be bundled in the same premarket approval application, according to an FDA bundling guidance
Modular PMA Guidance Issued As Program’s Premarket Approval Yield Grows
FDA's new guidance on modular premarket approval applications includes measures designed to ensure ample time for reviewers to evaluate the submissions